NG
Healthcare & Life Sciences
Ngenebio
South Koreangenebio.com/
Ngenebio is a Healthcare & Life Sciences startup based in South Korea, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Ngenebio
Ngenebio is a company headquartered in South Korea. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ngenebio develops next-generation sequencing (NGS)-based precision diagnostic products and software, focusing on oncology, infectious disease diagnostics, genomic data analysis, and integrated hospital data systems.
Explore Ngenebio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.